stockportfolio.pro
Halozyme Therapeutics, Inc. Gross Profit 2009–2025
Halozyme Therapeutics, Inc. (HALO) annual gross profit by fiscal year, computed from SEC filings. Compound growth +32.2%/yr over 16 years.
| Fiscal year | Gross Profit | Gross margin | Change (YoY) |
|---|---|---|---|
| FY 2025 | $1.17B | 83.6% | +36.4% |
| FY 2024 | $855.91M | 84.3% | +34.4% |
| FY 2023 | $636.89M | 76.8% | +22.3% |
| FY 2022 | $520.81M | 78.9% | +43.9% |
| FY 2021 | $361.90M | 81.6% | +61.4% |
| FY 2020 | $224.23M | 83.8% | +49.0% |
| FY 2019 | $150.45M | 76.8% | +6.2% |
| FY 2018 | $141.73M | 93.3% | -50.4% |
| FY 2017 | $285.46M | 90.2% | +151.5% |
| FY 2016 | $113.48M | 77.4% | +7.3% |
| FY 2015 | $105.81M | 78.3% | +101.2% |
| FY 2014 | $52.60M | 69.8% | +8.3% |
| FY 2013 | $48.55M | 88.6% | +17.8% |
| FY 2012 | $41.23M | 97.4% | -26.1% |
| FY 2011 | $55.83M | 99.5% | +341.7% |
| FY 2010 | $12.64M | 92.8% | -5.4% |
| FY 2009 | $13.36M | 97.7% | — |
Source: Halozyme Therapeutics, Inc. SEC filings — income statement (10-K). Refreshed nightly.
See the full picture for Halozyme Therapeutics, Inc.
Complete income statement, balance sheet and cash flow with trend on every row, 48 quarters, ratios, health checks, and Ask — the SEC-grounded research assistant.
Open the interactive view — freeHalozyme Therapeutics, Inc. — frequently asked questions
What is Halozyme Therapeutics, Inc.'s gross profit?
Halozyme Therapeutics, Inc. (HALO) reported gross profit of $1.17B for fiscal year 2025, per its SEC filings.
How has Halozyme Therapeutics, Inc.'s gross profit changed over time?
Between fiscal 2009 and 2025, HALO's gross profit grew at roughly 32.2% per year (compound annual rate), from $13.36M to $1.17B.
Where does this data come from?
Figures are computed from Halozyme Therapeutics, Inc.'s official SEC filings (income statement (10-K)), refreshed nightly. Not investment advice.